$SOTK

SONO TEK CORP

Sono-Tek designs and manufactures ultrasonic coating systems that apply precise, thin films to parts and components for microelectronics and electronics, medical, industrial, alternative energy, and research and development markets. Its systems use ultrasonic vibrations to atomize liquids into fine drops. Products include Multi-Axis Coating Systems, Integrated Coating Systems, Fluxing Systems, OEM Systems and Universal Align subsystems. The equipment is used in applications such as coating printed circuit boards, medical devices, glass, textiles, food packaging, fuel cells and solar cells. Sono-Tek sells primarily through direct sales personnel, independent distributors and sales representatives to original equipment manufacturers, distributors and end users. It also provides application consulting and coating services, supporting customers’ process development and optimization. The company is headquartered in Milton, New York, where its production facilities are located, and has sales and service and application development facilities in Singapore and Guangzhou, China.

No enriched coverage for $SOTK in the last 7 days.

No SEC Form 4 filings for $SOTK in the last 30 days.

See all $SOTK insider activity →
High

Northland upgrades Sono-Tek stock rating citing order backlog

Northland upgraded Sono-Tek (SOTK) to Outperform with a $7.00 price target, citing a strong order backlog and attractive valuation. The company has $10.8M in orders for the next fiscal year and a solid financial position. Despite missing Q2 earnings estimates, Sono-Tek showed revenue growth and higher margins. The stock trades at $5.26, considered undervalued by InvestingPro.

Earnings call transcript: Sono-Tek misses Q2 2027 estimates as shares fall 11%

Sono-Tek Corp. reported Q2 2027 earnings below expectations, with EPS of $0.02 (vs. $0.04 estimate) and revenue of $5.23M (vs. $5.56M estimate). Shares fell 11.1% premarket. Despite revenue growth and margin expansion, management expects flat to modest growth for the rest of fiscal 2027. The company's backlog grew to $10.79M, driven by large medical and alternative-energy orders.

SOTK sentiment & insider activity

Recent SOTK coverage spans financial news, earnings and market movers.

What's driving SOTK

  • Upgrade and price target suggest upside potential.

    investing.com · Oct 26, 2026

  • Sono-Tek Corp. reported Q2 2027 earnings below expectations, with EPS of $0.02 (vs. $0.04 estimate) and revenue of $5.23M (vs. $5.56M estimate). Shares fell 11.1% premarket. Despite revenue growth and margin expansion, management expects flat to modest growth for the rest of fiscal 2027. The company's backlog grew to $10.79M, driven by large medical and alternative-energy orders.

    investing.com · Oct 14, 2026

  • Earnings preview; no new guidance disclosed.

    benzinga.com · Oct 14, 2026

  • Earnings miss and lower guidance pressure the stock lower.

    investing.com · Oct 14, 2026

  • Strong medical‑sector sales and higher‑value systems drove earnings beat, but guidance remains unchanged.

    SEC EDGAR 8-K · Oct 14, 2026

AlphAI scores every news story that mentions SOTK with an AI model for sentiment and relevance, and aggregates insider trades from SONO TEK CORP's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $SOTK

Score

Northland upgrades Sono-Tek stock rating citing order backlog

Northland upgraded Sono-Tek (SOTK) to Outperform with a $7.00 price target, citing a strong order backlog and attractive valuation. The company has $10.8M in orders for the next fiscal year and a solid financial position. Despite missing Q2 earnings estimates, Sono-Tek showed revenue growth and higher margins. The stock trades at $5.26, considered undervalued by InvestingPro.

Earnings call transcript: Sono-Tek misses Q2 2027 estimates as shares fall 11%

Sono-Tek Corp. reported Q2 2027 earnings below expectations, with EPS of $0.02 (vs. $0.04 estimate) and revenue of $5.23M (vs. $5.56M estimate). Shares fell 11.1% premarket. Despite revenue growth and margin expansion, management expects flat to modest growth for the rest of fiscal 2027. The company's backlog grew to $10.79M, driven by large medical and alternative-energy orders.

Sono-Tek Reports Fiscal Second Quarter and First Half 2027 Results Driven by Strong Medical Sector and Higher Value Production Systems

SONO TEK CORP (SOTK) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Sono-Tek Reports Fiscal Second Quarter and First Half 2027 Results Driven by Strong Medical Sector and Higher Value Production Systems First Half Revenue Increased 6% to $10.9 Million; Gross Margin Expanded to 55%; Operating Income Increased 41%; Medical Market Sales

SonoTek (SOTK) Moves 18.5% Higher: Will This Strength Last?

Sono-Tek (SOTK) shares rose 18.5% to $5.9 on high volume. The company benefits from increased demand for its ultrasonic coating systems in clean energy. Q2 earnings are expected at $0.05 per share, up 66.7% YoY, with revenues at $5.68M, up 10.1% YoY. The consensus EPS estimate has not changed in 30 days. GlobalFoundries (GFS) also mentioned, up 0.1% to $47.92, with a 9% monthly return.

Related tickers